Operating Income for AstraZeneca (AZN)
According to AstraZeneca's latest reported financial statements, the company's current operating income (TTM) is $13.74B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
AZN
Currently viewingRevenueSwitch metric
TTM (last 4 quarters)
$13.74B
YoY change
+37.4%
5Y CAGR
+21.6%
Peak year (2025)
$13.74B
Cumulative operating income
$178.73B
Operating Income history chart for AstraZeneca (AZN) from 1990 to 2025
Operating Income history table for AstraZeneca (AZN) from 1990 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $13.74B | +37.4% | ||
| 2024 | $10.00B | +22.1% | ||
| 2023 | $8.19B | +118.1% | ||
| 2022 | $3.76B | +255.8% | ||
| 2021 | $1.06B | -79.5% | ||
| 2020 | $5.16B | +76.5% | ||
| 2019 | $2.92B | -13.7% | ||
| 2018 | $3.39B | -7.9% | ||
| 2017 | $3.68B | -25.0% | ||
| 2016 | $4.90B | +19.2% | ||
| 2015 | $4.11B | +92.5% | ||
| 2014 | $2.14B | -42.4% | ||
| 2013 | $3.71B | -54.4% | ||
| 2012 | $8.15B | -36.3% | ||
| 2011 | $12.79B | +11.3% | ||
| 2010 | $11.49B | -0.4% | ||
| 2009 | $11.54B | +26.2% | ||
| 2008 | $9.14B | +13.0% | ||
| 2007 | $8.09B | -1.5% | ||
| 2006 | $8.22B | +26.4% | ||
| 2005 | $6.50B | +43.0% | ||
| 2004 | $4.55B | +13.5% | ||
| 2003 | $4.01B | +0.0% | ||
| 2002 | $4.01B | -3.6% | ||
| 2001 | $4.16B | +13.4% | ||
| 2000 | $3.67B | +6.9% | ||
| 1999 | $3.43B | +41.3% | ||
| 1998 | $2.43B | +35.6% | ||
| 1997 | $1.79B | +0.2% | ||
| 1996 | $1.79B | +39.4% | ||
| 1995 | $1.28B | +24.3% | ||
| 1994 | $1.03B | -1.1% | ||
| 1993 | $1.04B | +142.6% | ||
| 1992 | $429.22M | -66.4% | ||
| 1991 | $1.28B | +10.3% | ||
| 1990 | $1.16B | — |
Operating Income values are taken from AstraZeneca's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
The 2025 reading of AstraZeneca (AZN) operating income is $13.74B – surged 37.4% year-over-year.
Looking at the 2020–2025 (5 years) stretch, AstraZeneca operating income compounded at +21.6% per year, sustaining 4 straight years of year-over-year growth.
2025 marks the peak operating income at $13.74B, with the historical low of $429.22M recorded in 1992.
Among 8 Healthcare peers, AstraZeneca (AZN) ranks 7th; the peer median for operating income is $22.84B.
AstraZeneca Operating Income by Year
AstraZeneca Operating Income 2025: $13.74B
AstraZeneca operating income in 2025 was $13.74B, surged 37.4% from 2024. This figure represents the highest annual value in the available history.
AstraZeneca Operating Income 2024: $10.00B
AstraZeneca operating income in 2024 was $10.00B, grew 22.1% from 2023.
AstraZeneca Operating Income 2023: $8.19B
AstraZeneca operating income in 2023 was $8.19B, surged 118.1% from 2022.
AstraZeneca Operating Income 2022: $3.76B
AstraZeneca operating income in 2022 was $3.76B, surged 255.8% from 2021.
AstraZeneca Operating Income 2021: $1.06B
AstraZeneca operating income in 2021 was $1.06B.
See more financial history for AstraZeneca (AZN).
Sector peers — Operating Income
Companies in the same sector as AstraZeneca, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
| Thermo Fisher Scientific Inc. (TMO) | $8.11B | Healthcare |
Frequently asked questions
What is AstraZeneca's operating income?
- Latest reported operating income for AstraZeneca (AZN) is $13.74B (period ending December 31, 2025).
How has AstraZeneca operating income changed year-over-year?
- AstraZeneca (AZN) operating income changed +37.4% year-over-year on the latest annual filing.
What is the long-term growth rate of AstraZeneca operating income?
- AstraZeneca (AZN) operating income compound annual growth rate is +21.6% over the most recent 5 years available.
When did AstraZeneca operating income hit its highest annual value?
- AstraZeneca operating income reached its highest annual value of $13.74B in 2025.
What was AstraZeneca operating income in 2024?
- AstraZeneca (AZN) operating income in 2024 was $10.00B.
What was AstraZeneca operating income in 2025?
- AstraZeneca (AZN) operating income in 2025 was $13.74B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
AZN Overview
Company profile, financial tools, and key metrics
AZN Revenue Counter
Earns $1,863 every second. See per minute, hour, and day.
AZN Earnings Counter
Earns $324.23 per second net profit. See per minute, hour, and day.
AZN Economic Scale
Exceeds Bolivia's GDP. Compare with world economies.
AZN What If Invested
What if you had invested $1,000? See historical returns from any date.
AZN How It Makes Money
Discover visual breakdown of $58.74B in revenue — where it comes from and where it goes.
AZN Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
AZN Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
AZN Daily Price Character
Steady · 49.4% historical win rate (green days). Streaks & record days.
AZN Buybacks
0.16% TTM buyback yield. Shareholder yield & SBC comparison.
AZN Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.
AZN Dividend Profile
Yield: 1.73%. Safety: 6/8. See full history.
AZN Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
AZN Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.